← Back to Intel
Insider ActivityGDTC
Choo Chee Kong, Director, 10% Owner at CytoMed Therapeutics Ltd, bought $129K of GDTC
Updated Jun 19, 2026
Choo Chee Kong
Director, 10% Owner
CytoMed Therapeutics Ltd ·
$GDTC
Transaction Details
| Insider | Choo Chee Kong |
|---|---|
| Title | Director, 10% Owner |
| Company | CytoMed Therapeutics Ltd |
| Ticker | GDTC |
| Transaction Type | Purchase |
| Transaction Date | 2026-05-13 |
| Shares Traded | 112,000 |
| Price Per Share | $1.1498 |
| Total Value | $129K |
| Filed Date | 2026-06-15 |
| Accession Number | 0001493152-26-028589 |
Ownership Context
| Shares Owned After Transaction | 430,324 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001493152-26-028589
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for GDTC — CytoMed Therapeutics Ltd →
Track GDTC insider activity in real time on The Wire →
Get alerts when Choo Chee Kong files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 19, 2026 at 07:12 UTC